Fundraising FoxTearClear
Copley, US · Founded 2015 · Delaware corporation · 4 known investors
Find your way into TearClear
Sign up to find every way you can get introduced to TearClear
- Your email: who you already know at TearClear, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the TearClear team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
Board
WL
JW
TS
Tyler StowaterBoard director
RH
Richard HeinickBoard director
SP
Steve PazolBoard director
Investors · 4
Flying L Partnerslisted by Flying L Partners
How we know: Flying L Partners's portfolio page · Not right? Tell us
Versant Venture AIV HoldingsinferredSan Francisco
How we know: board seat on SEC Form D · Not right? Tell us
Visionary VenturereportedAliso Viejo
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$52.4M disclosed across 6 rounds · 2017–2023
▶$11.8MraisedJul 2023 · 70 investors · PharmaceuticalsRule 506(b)
▶$11.8MraisedJul 2023 · 70 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Richard HeinickDirector
- Tyler StowaterDirector
- Stuart RaetzmanDirector
- Srini VenkateshExecutive Officer
- Richard HarrisonExecutive Officer
- William LinkDirector
- Jeffry WeinhuffDirector
- Offering amount
- $16M
- Amount sold
- $11.8M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.9MraisedAug 2022 · 43 investors · PharmaceuticalsRule 506(b)
▶$5.9MraisedAug 2022 · 43 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Robert BaileyDirector
- Kevin HershfieldExecutive Officer
- Richard HeinickDirector
- Tyler StowaterDirector
- Jeffry WeinhuffDirector
- Stuart RaetzmanExecutive Officer, Director
- William LinkDirector
- Offering amount
- $10M
- Amount sold
- $5.9M
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$22.3MraisedAug 2020 · 51 investors · PharmaceuticalsRule 506(b)
▶$22.3MraisedAug 2020 · 51 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Tyler StowaterDirector
- Steve PazolDirector
- Kevin HershfieldExecutive Officer
- William LinkDirector
- Robert DempseyExecutive Officer, Director
- Richard HeinickDirector
- Jeffry WeinhuffDirector
- Offering amount
- $26M
- Amount sold
- $22.3M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$2.8MraisedFeb 2020 · 32 investors · PharmaceuticalsRule 506(b)
▶$2.8MraisedFeb 2020 · 32 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Richard HeinickDirector
- Kevin HershfieldExecutive Officer, Director
- William LinkDirector
- Steve PazolDirector
- Jeffry WeinhuffDirector
- Tyler StowaterDirector
- Offering amount
- $3M
- Amount sold
- $2.8M
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$5MraisedFeb 2019 · 22 investors · BiotechnologyRule 506(b)
▶$5MraisedFeb 2019 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tyler StowaterDirector
- William LinkDirector
- Steve PazolDirector
- Kevin HershfieldExecutive Officer, Director
- Jeffry WeinhuffDirector
- Richard HeinickDirector
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Feb 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$4.6MraisedMay 2017 · 11 investors · BiotechnologyRule 506(b)
▶$4.6MraisedMay 2017 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William LinkDirector
- Kevin HershfieldExecutive Officer, Director
- Richard HeinickDirector
- Steve PazolDirector
- Jeffry WeinhuffDirector
- Tyler StowaterDirector
- Offering amount
- $4.6M
- Amount sold
- $4.6M
- First sale
- May 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through TearClear went on to found or lead other companies.
Related companies · 2
TearSolutionsTearSolutions develops Lacripep, a topical peptide therapy derived from the Lacritin protein for the treatment of dry eye disease, including cases associated with primary Sjögren's Syndrome. The company is running clinical trials of the drug candidate for patients with moderate to severe dry eye.
RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Companies working in the same space as TearClear.
In the news
Frequently asked questions
- Who are TearClear's investors?
- TearClear's investors include Flying L Partners, Visionary Ventures, Versant Venture AIV Holdings, Visionary Venture.
- How much funding has TearClear raised?
- TearClear has disclosed $52.4M raised across 6 rounds.
- Where is TearClear headquartered?
- TearClear is headquartered in Copley, US.